Veronica McNally
Director of Trial Advocacy; Director of Externships Michigan State University
Media
Biography
Her commitment to legal excellence and ethics is evident in her extensive service on the State Bar of Michigan's (SBM) Standing Committee on Character and Fitness from 2005 to 2013 and her tenure on the SBM Young Lawyers Executive Council between 2005 and 2007. In 2023, she presented at Temple University Beasley School of Law’s Training Advocates Conference, and in 2024, she served on the steering committee for the Hillman Advocacy Program. Recognized for her exceptional contributions to the field, Law & Politics honored her as a Rising Star for six consecutive years, from 2010 to 2016. She earned a Master Advocate Designation from the National Institute of Trial Advocacy in 2016.
Beyond her legal accomplishments, McNally is a fervent advocate for public health, seamlessly integrating her legal expertise with a passion for societal well-being. In 2018, she was appointed by the United States Secretary of Health and Human Services to serve on the CDC’s Advisory Committee on Immunization Practices (ACIP) for a four-year term as ACIP’s consumer representative. She was re-appointed for a fifth year. In this role, she provided perspectives on the social and community aspects of vaccination. The ACIP develops recommendations on how to use vaccines to control disease in the United States.
Areas of Expertise
Accomplishments
Law & Politics Rising Star
2010-2016
Education
Michigan State University College of Law
J.D.
University of Michigan
B.A.
News
Michigan reports 1,500+ whooping cough cases, up from 110 in 2023
WXYZ Channel 7 tv
2024-12-12
Veronica McNally from West Bloomfield has made it her life's work to talk about vaccines and pertussis, also known as whooping cough.
Detroit Rising Podcast
Crain's Detroit Business online
2020-12-09
This week on Detroit Rising podcast: Veronica McNally, an Oakland County attorney who founded the I Vaccinate campaign, talks with Crain's Senior Editor Chad Livengood about the challenges ahead with distributing a COVID-19 vaccine and whether employers should mandate it for their workers.
Journal Articles
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger - United States, 2023
Morbidity and Mortality Weekly Report2023
At its October 2022 meeting, the Advisory Committee on Immunization Practices* (ACIP) approved the Recommended Child and Adolescent Immunization Schedule for Ages 18 Years or Younger, United States, 2023. The 2023 child and adolescent immunization schedule, available on the CDC immunization schedule website (https://www.cdc.gov/vaccines/schedules), summarizes ACIP recommendations, including several changes from the 2022 immunization schedule† on the cover page, tables, notes, and appendix. Health care providers are advised to use the tables, notes, and appendix together to determine recommended vaccinations for patient populations.
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older - United States, 2023
Morbidity and Mortality Weekly Report2023
At its October 2022 meeting, the Advisory Committee on Immunization Practices* (ACIP) approved the Recommended Adult Immunization Schedule for Ages 19 Years or Older, United States, 2023. The 2023 adult immunization schedule summarizes ACIP recommendations, including several changes to the cover page, tables, notes, and appendix from the 2022 immunization schedule.† This schedule can be found on the CDC immunization schedule website (https://www.cdc.gov/vaccines/schedules). Health care providers are advised to use the cover page, tables, notes, and appendix together to determine recommended vaccinations for patient populations.
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2022
Morbidity and Mortality Weekly Report2022
At its November 2021 meeting, the Advisory Committee on Immunization Practices* (ACIP) approved the Recommended Adult Immunization Schedule for Ages 19 Years or Older, United States, 2022. The 2022 adult immunization schedule summarizes ACIP recommendations, including several changes to the cover page, tables, and notes from the 2021 immunization schedule.† In addition, the 2022 adult immunization schedule provides an appendix that lists the contraindications to and precautions for all routinely recommended vaccines in the schedule. This schedule can be found on the CDC immunization schedule website (https://www.cdc.gov/vaccines/schedules). Health care providers are advised to use the cover page, tables, notes, and appendix together.
Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021
Morbidity and Mortality Weekly Report2021
Dengue is a vectorborne infectious disease caused by dengue viruses (DENVs), which are predominantly transmitted by Aedes aegypti and Aedes albopictus mosquitos. Dengue is caused by four closely related viruses (DENV-1-4), and a person can be infected with each serotype for a total of four infections during their lifetime. Areas where dengue is endemic in the United States and its territories and freely associated states include Puerto Rico, American Samoa, the U.S. Virgin Islands, the Federated States of Micronesia, the Republic of Marshall Islands, and the Republic of Palau. This report summarizes the recommendations of the Advisory Committee on Immunization Practices (ACIP) for use of the Dengvaxia vaccine in the United States.
